Yeliz Pekcevik

Yeliz Pekcevik

Auto-generated profile, based on publicly available information

Yeliz Pekcevik

Department of Radiology, Izmir Tepecik Training and Research Hospital, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2013 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
YPYeliz Pekcevik
Yeliz Pekcevik
RPRidvan Pekcevik
Ridvan Pekcevik

1 January 2017 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
RARamazan Aslaner
Ramazan Aslaner
YPYeliz Pekcevik
Yeliz Pekcevik
HSHilal Sahin
Hilal Sahin
OTOnur Toka
Onur Toka
Aslaner R, et al. Korean J Radiol. 2017 Mar-Apr;18(2):336-344. https://doi.org/10.3348/kjr.2017.18.2.336

31 December 2013 in Journal of Clinical Imaging Science
Verified
Journal Article
Open access
PDF file
YPYeliz Pekcevik
Yeliz Pekcevik
MKMehmet Onur Kahya
Mehmet Onur Kahya
AKAhmet Kaya
Ahmet Kaya
Objective: The study aims to determine whether apparent diffusion coefficient (ADC) can help differentiate benign and malignant bone tumors. Materials and Methods: From January 2012 to February 2013, we prospectively included 26 patients. Of these 15 patients were male and 11 were female; ranging in age from 8 to 76 years (mean age, 34.5 years). Diffusion-weighted magnetic resonance (MR) imaging was obtained with a single-shot echo-planar imaging sequence using a 1.5T MR scanner. We grouped malignant lesions as primary, secondary, and primary tumor with chondroid matrix. The minimum ADC was measured in the tumors and mean minimum ADC values were selected for statistical analysis. ADC values were compared between malignant and benign tumors using the Mann-Whitney U-test and receiver operating curve analysis were done to determine optimal cut-off values. Results: The mean ADC values from the area with lowest ADC values of benign and malignant tumors were 1.99 ± 0.57 × 10−3 mm2/s and 1.02 ± 1.0 × 10−3 mm2/s, respectively. The mean minimum ADC values of benign and malignant tumors were statistically different (P = 0.029). With cut-off value of 1.37 (10−3 mm2/s), sensitivity was 77.8% and specificity was 82.4%, for distinguishing benign and malignant lesion. Benign and secondary malignant tumors showed statistically significant difference (P = 0.002). There was some overlap in ADC values between benign and malignant tumors. The mean minimum ADC values of benign and malignant chondroid tumors were high. Giant cell tumor, non-ossifying fibroma and fibrous dysplasia showed lower ADC values. Conclusion: Although there is some overlap, ADC values of benign and malignant bone tumors seem to be different. Further studies with larger patient groups are needed to find an optimal cut-off ADC value.

1 May 2016 in Clinical Imaging
Verified
Journal Article
Closed access
YPYeliz Pekcevik
Yeliz Pekcevik
GOGunes Orman
Gunes Orman
ILIn Ho Lee
In Ho Lee
MMMaureen A. Mealy
Maureen A. Mealy
MLMichael Levy
Michael Levy
IIIzlem Izbudak
Izlem Izbudak

1 April 2014 in Journal of Neurosciences in Rural Practice
Verified
Journal Article
Open access
PDF file
YPYeliz Pekcevik
Yeliz Pekcevik
HSHilal Sahin
Hilal Sahin
RPRidvan Pekcevik
Ridvan Pekcevik
Purpose: We assessed the prevalence of the clinically important posterior fossa emissary veins detected on computed tomography (CT) angiography. Materials and Methods: A total of 182 consecutive patients who underwent 64-slice CT angiography were retrospectively reviewed to determine the clinically important posterior fossa emissary veins. Results: Of 166 patients, the mastoid emissary vein (MEV) was not identified in 37 (22.3%) patients. It was found bilaterally in 82 (49.4%) and unilaterally in 47 (28.3%) patients. Only six patients had more than one MEV that were very small (5 mm) veins. The posterior condylar vein (PCV) was not identified in 39 (23.5%) patients. It was found bilaterally in 97 (58.4%) and unilaterally in 30 (18.1%) patients. Only 15 patients had a very large (>5 mm) PCV. The petrosquamosal sinus (PSS) was identified only in one patient (0.6%) on the left side. The occipital sinus was found in two patients (1.2%). Conclusions: The presence of the clinically important posterior fossa emissary veins is not rare. Posterior fossa emissary veins should be identified and systematically reported, especially prior to surgeries involving the posterior fossa and mastoid region.

20 September 2013 in Diagnostic and Interventional Radiology
Verified
Journal Article
Closed access
YPYeliz Pekcevik
Yeliz Pekcevik
RPRidvan Pekcevik
Ridvan Pekcevik
Diagnostic and Interventional Radiology